These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 28058579)
1. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer. Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579 [TBL] [Abstract][Full Text] [Related]
2. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH Oncology; 2004; 66(6):429-38. PubMed ID: 15452371 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy. Boye K; Jacob H; Frikstad KA; Nesland JM; Maelandsmo GM; Dahl O; Nesbakken A; Flatmark K Cancer Med; 2016 Aug; 5(8):1840-9. PubMed ID: 27273130 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128 [TBL] [Abstract][Full Text] [Related]
5. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. de Silva Rudland S; Martin L; Roshanlall C; Winstanley J; Leinster S; Platt-Higgins A; Carroll J; West C; Barraclough R; Rudland P Clin Cancer Res; 2006 Feb; 12(4):1192-200. PubMed ID: 16489073 [TBL] [Abstract][Full Text] [Related]
6. Nuclear S100A4 is a novel prognostic marker in colorectal cancer. Boye K; Nesland JM; Sandstad B; Mælandsmo GM; Flatmark K Eur J Cancer; 2010 Nov; 46(16):2919-25. PubMed ID: 20719498 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer. Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma. Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314 [TBL] [Abstract][Full Text] [Related]
9. Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features. Hussein S; Mosaad H; Rashed HE; Ahmed S; Ragab A; Ismail EI Mol Biol Rep; 2017 Aug; 44(4):365-377. PubMed ID: 28808805 [TBL] [Abstract][Full Text] [Related]
10. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma. Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of S100A4 Predicts Migration, Invasion, and Poor Prognosis of Hypopharyngeal Squamous Cell Carcinoma. Xu J; Gross N; Zang Y; Cao S; Yang F; Yang Z; Yu W; Lei D; Pan X Mol Diagn Ther; 2019 Jun; 23(3):407-417. PubMed ID: 30868407 [TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer. An X; Xu F; Luo R; Zheng Q; Lu J; Yang Y; Qin T; Yuan Z; Shi Y; Jiang W; Wang S BMC Cancer; 2018 Mar; 18(1):331. PubMed ID: 29587760 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer. Kang YG; Jung CK; Lee A; Kang WK; Oh ST; Kang CS J Surg Oncol; 2012 Feb; 105(2):119-24. PubMed ID: 21837681 [TBL] [Abstract][Full Text] [Related]
14. Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer. Flatmark K; Pedersen KB; Nesland JM; Rasmussen H; Aamodt G; Mikalsen SO; Bjørnland K; Fodstad Ø; Maelandsmo GM J Pathol; 2003 Aug; 200(5):589-95. PubMed ID: 12898594 [TBL] [Abstract][Full Text] [Related]
15. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients. Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of S100A4 expression in gallbladder cancer. Nakamura T; Ajiki T; Murao S; Kamigaki T; Maeda S; Ku Y; Kuroda Y Int J Oncol; 2002 May; 20(5):937-41. PubMed ID: 11956586 [TBL] [Abstract][Full Text] [Related]
17. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma. Roh J; Knight S; Chung JY; Eo SH; Goggins M; Kim J; Cho H; Yu E; Hong SM J Clin Pathol; 2014 Mar; 67(3):216-21. PubMed ID: 24062356 [TBL] [Abstract][Full Text] [Related]
18. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [TBL] [Abstract][Full Text] [Related]
19. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas. Zhao Y; Zhang T; Wang Q Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849 [TBL] [Abstract][Full Text] [Related]
20. Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer. Hemandas AK; Salto-Tellez M; Maricar SH; Leong AF; Leow CK J Surg Oncol; 2006 May; 93(6):498-503. PubMed ID: 16615153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]